- AU$80.89m
- AU$61.23m
- AU$1.62m
Brief: LTR Pharma Executes Exclusive Pilot Agreement With Marius Pharmaceuticals, Inc For Kyzatrex
Brief: LTR Pharma Executes U.S. Commercial Agreement With Strive
Australia's LTR Pharma rises on commercial tie-up with US telehealth firm
Australia's LT Pharma gains after nod to test nasal spray
Brief: LTR Pharma Says Oroflow Becomes First GI Application Of Intranasal Platform
Australia's LTR Pharma gains on US deal for Roxus
Australia's LTR Pharma hits over a month high on US distribution deal
Brief: LTR Pharma Secures First U.S. Commercial Agreement For Roxus
Australia's LTR Pharma gains most in nearly 2 years on positive FDA drug trial
Brief: LTR Pharma Seeks Trading Halt
Australia's LTR Pharma rises on TGA nod for SPONTAN Phase II clinical study
Brief: LTR Pharma Increases LevOmega Stake To 43% With A$1M Investment
Brief: LTR Pharma Secures 33% Ownership In Levomega
Australia's LTR Pharma rises on securing stake in LevOmega
Brief: LTR Pharma Signs Collaborative Agreement To Develop OMD Nasal Spray
Australia's LTR Pharma rises on new drug partnership deal
Brief: Ltr Pharma Says FDA Provides Path To Approval For Spontan
Brief: LTR Pharma Signs National Pharmacy Distribution Agreement With Symbion
Australia's LTR Pharma rises on distribution deal for its erectile dysfunction product